GeneTether Therapeutics Inc. (GNTTF) and trades at $0.01. The 52-week range is 0.01-0.0272.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.7, Earnings Per Share (EPS) of $-0.02.
The stock has a beta of 0.00, operates in the Healthcare sector.
